we are organized into three divisions across six physical locations . our instruments division designs , manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare , pharmaceutical , food and beverage , medical device , industrial hygiene , environmental air sampling and semiconductor industries . our biological indicators division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes , including steam , hydrogen peroxide , ethylene oxide and radiation , in the hospital , dental , medical device and pharmaceutical industries . our continuous monitoring division designs , develops and markets systems which are used to monitor various environmental parameters such as temperature , humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals , pharmaceutical and medical device manufacturers , blood banks , pharmacies and a number of other laboratory and industrial environments . we follow a philosophy of manufacturing a high quality product and providing a high level of on-going service for those products . our revenues come from two main sources – product sales and services . product sales are dependent on several factors , including general economic conditions , both domestic and international , customer capital spending trends , competition , introduction of new products and acquisitions . biological indicator products are disposable and are used on a routine basis for quality control , thus product sales are less sensitive to general economic conditions . instrument products and continuous monitoring systems have a longer life , and their purchase by our customers is somewhat discretionary , so sales are more sensitive to general economic conditions . service demand is driven by our customers ' quality control and regulatory environments , which require periodic repair and recalibration or certification of our instrument products and continuous monitoring systems . we typically evaluate costs and pricing annually . our policy is to price our products and systems competitively and , where possible , we try to pass along cost increases in order to maintain our margins . gross profit is affected by our product mix , manufacturing efficiencies and price competition . historically , as we have integrated our acquisitions and taken advantage of manufacturing efficiencies , our gross margins for some of the products have improved . there are , however , differences in gross margins between different product lines , and ultimately the mix of sales will continue to impact our overall gross margin . selling expense is driven primarily by labor costs , including salaries and commissions . accordingly , it may vary with sales levels . labor costs and amortization of intangible assets drive the substantial majority of general and administrative expense . research and development expense is predominantly comprised of labor costs and third party consultants . year ended march 31 , 2015 acquisitions during the year ended march 31 , 2015 , we completed the following six acquisitions ( the “ 2015 acquisitions ” ) : in march 2015 , we completed the früh acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of früh 's business segment associated with the distribution of our biological indicator products ; in february 2015 , we completed the cherwell acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of cherwell 's business segment associated with the distribution of our biological indicator products ; in october 2014 , we completed the ati acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of ati , a distributor of our biological indicator products ; in october 2014 , we completed the pcd acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of pcd 's business segment associated with the sale of pcd 's which are used for quality control purposes in the field of ethylene oxide sterilization of medical devices ; page 18 in april 2014 , we completed the bgi acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of bgi 's business which is focused on the sale of equipment used primarily for particulate air sampling ; and in april 2014 , we completed the amilabo acquisition whereby we acquired all of the common stock of amilabo , a distributor of our biological indicator products . year ended march 31 , 2014 acquisitions during the year ended march 31 , 2014 , we completed the following three acquisitions ( the “ 2014 acquisitions ” ) : in november 2013 , we completed the tempsys acquisition whereby we acquired all of the common stock of tempsys , a company in the business of providing continuous monitoring systems to regulated industries ; in november 2013 , we completed the amega acquisition whereby we acquired substantially all of the assets ( other than cash ) and certain liabilities of amega , a company in the business of providing continuous monitoring services to regulated industries ; and in july 2013 , we completed the suretorque acquisition whereby we acquired substantially all the assets ( other than cash ) of st acquisition 's business segment involving the design , manufacture , sale and service of its suretorque line of bottle cap torque testing instrumentation . story_separator_special_tag while our estimates and assumptions are based on our knowledge of current events and actions we may undertake in the future , actual results may ultimately differ from these estimates and assumptions . for a discussion of our significant accounting policies , please see note 1 of notes to consolidated financial statements contained in “ item 8. financial statements and supplementary data . ” accounts receivable we estimate an allowance for doubtful accounts based on overall historic write-offs , the age of our receivable balances , and the payment history and creditworthiness of the customer . if actual results are not consistent with our assumptions and judgments or our assumptions and estimates change due to new information , we may experience material changes in our allowance for doubtful accounts and bad debt expense . inventories inventories are stated at the lower of cost or market , based on standards using the first-in , first-out method ( fifo ) to determine cost . we evaluate standard costs annually , unless circumstances necessitate a mid-year evaluation for specific items . our work in process and finished goods inventory includes labor and overhead , which are estimated based on trailing twelve months of expense and standard labor hours for each product . our biological indicator inventory is tracked by lot number , thus labor is generally based on actual hours . we monitor inventory cost compared to selling price in order to determine if a lower of cost or market reserve is necessary . at year end we perform a complete physical inventory observation . throughout the year , we estimate and maintain an inventory reserve , as needed , for such matters as obsolete inventory , shrink and scrap . this reserve may fluctuate as our assumptions change due to new information , discrete events , or changes in our business , such as entering new markets or discontinuing a specific product . page 26 recoverability of long-lived assets for property , plant and equipment , and intangible assets subject to amortization , recoverability and or impairment tests are required only when conditions exist that indicate the carrying value may not be recoverable . we monitor the same conditions for our goodwill , but an annual evaluation is also required . monitoring these conditions requires significant management judgment , including evaluating general economic conditions , industry and market considerations , changes in production costs , cash flow trends , and other relevant entity-specific events such as changes in management , key personnel , strategy or customers . if conditions exist that indicate the carrying value may not be recoverable , we would be required to estimate the fair value of the asset , asset group , or reporting unit . we determine fair value using widely accepted valuation techniques , primarily discounted cash flow and market multiple analyses . these techniques are also used when initially allocating the purchase price to acquired assets and liabilities . these types of analyses require us to make assumptions and estimates regarding industry and economic factors , the profitability of future business strategies , and cash flow . we did not record any impairment charges for the years ended march 31 , 2015 , 2014 or 2013. if actual results are not consistent with our assumptions and estimates , or our assumptions and estimates change due to new information , we may be exposed to an impairment charge in the future . purchase accounting for acquisitions we apply the acquisition method of accounting for a business combination . in general , this methodology requires companies to record assets acquired and liabilities assumed at their respective fair market values at the date of acquisition . any amount of the purchase price paid that is in excess of the estimated fair value of the net assets acquired is recorded as goodwill . for the pcd , amega and bios acquisitions , we also recorded a liability for contingent consideration based on estimated future revenues . we monitor our assumptions surrounding these estimated future cash flows and , if there is a significant change , would record an adjustment to the contingent consideration liability and a corresponding adjustment to either income or expense . we determine fair value using widely accepted valuation techniques , primarily discounted cash flow and market multiple analyses . these types of analyses require us to make assumptions and estimates regarding industry and economic factors , the profitability of future business strategies , discount rates and cash flow . if actual results are not consistent with our assumptions and estimates , or our assumptions and estimates change due to new information , we may be exposed to an impairment charge in the future . if the contingent consideration paid for any of our acquisitions differs from the amount initially recorded , we would record either income or expense . stock-based compensation we estimate the fair value of option grants using the black-scholes model , which requires us to estimate the volatility and forfeiture rate . under our current stock-based compensation plan , we recognize the expense on a straight-line basis over the service period . contingent liabilities we accrue a loss for contingencies if it is probable that an asset has been impaired or a liability has been incurred , and when the amount of loss can be reasonably estimable . when no accrual is made because one or both of these conditions does not exist , we disclose the contingency if there is at least a reasonable possibility that a loss may be incurred . we estimate contingent liabilities , such as for state sales taxes , based on the best information available at the time . if there is a range of possible outcomes , we accrue the low end of the range . recent accounting standards and pronouncements in may 2014 , the financial accounting standards board ( “ fasb ” ) and international accounting standards board ( “ iasb ” )

liquidity and capital resources our sources of liquidity may include cash generated from operations , working capital , capacity under our credit facility and potential equity and debt offerings . we believe that cash generated from these sources will be sufficient to meet our short-term and long-term needs . our more significant uses of resources include quarterly dividends to shareholders , payment of debt obligations , long-term capital equipment expenditures and potential acquisitions . page 23 due to continued organic and acquisition related growth , we have outgrown the capacity of our current building in bozeman , montana and as a result , we will build a new facility in the same general area . we expect that construction will begin in july 2015 and we are hopeful that the building will be completed no later than september 30 , 2016. during our year ended march 31 , 2015 we acquired the related land for $ 741,000 and we anticipate that the remaining cost of the new facility will be approximately $ 14,000,000. following the relocation from our current bozeman building into the new facility , we expect to be able to sell the current facility for $ 2,000,000 - $ 3,000,000 to partially offset the cost of the new building . we are currently implementing a new erp system which has required a significant amount of cash . we incurred $ 993,000 of expense associated with this project for the year ended march 31 , 2015. our expectation is that we will go live with our new erp system during our second quarter ending september 30 , 2015. we anticipate that we will incur up to $ 500,000 for activities necessary to go live and for related post go-live support . in addition , we may incur additional costs associated with software system upgrades . working capital is the amount by which current assets exceed current liabilities .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources our sources of liquidity may include cash generated from operations , working capital , capacity under our credit facility and potential equity and debt offerings . we believe that cash generated from these sources will be sufficient to meet our short-term and long-term needs . our more significant uses of resources include quarterly dividends to shareholders , payment of debt obligations , long-term capital equipment expenditures and potential acquisitions . page 23 due to continued organic and acquisition related growth , we have outgrown the capacity of our current building in bozeman , montana and as a result , we will build a new facility in the same general area . we expect that construction will begin in july 2015 and we are hopeful that the building will be completed no later than september 30 , 2016. during our year ended march 31 , 2015 we acquired the related land for $ 741,000 and we anticipate that the remaining cost of the new facility will be approximately $ 14,000,000. following the relocation from our current bozeman building into the new facility , we expect to be able to sell the current facility for $ 2,000,000 - $ 3,000,000 to partially offset the cost of the new building . we are currently implementing a new erp system which has required a significant amount of cash . we incurred $ 993,000 of expense associated with this project for the year ended march 31 , 2015. our expectation is that we will go live with our new erp system during our second quarter ending september 30 , 2015. we anticipate that we will incur up to $ 500,000 for activities necessary to go live and for related post go-live support . in addition , we may incur additional costs associated with software system upgrades . working capital is the amount by which current assets exceed current liabilities .
```    
 Suspicious Activity Report : we are organized into three divisions across six physical locations . our instruments division designs , manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare , pharmaceutical , food and beverage , medical device , industrial hygiene , environmental air sampling and semiconductor industries . our biological indicators division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes , including steam , hydrogen peroxide , ethylene oxide and radiation , in the hospital , dental , medical device and pharmaceutical industries . our continuous monitoring division designs , develops and markets systems which are used to monitor various environmental parameters such as temperature , humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals , pharmaceutical and medical device manufacturers , blood banks , pharmacies and a number of other laboratory and industrial environments . we follow a philosophy of manufacturing a high quality product and providing a high level of on-going service for those products . our revenues come from two main sources – product sales and services . product sales are dependent on several factors , including general economic conditions , both domestic and international , customer capital spending trends , competition , introduction of new products and acquisitions . biological indicator products are disposable and are used on a routine basis for quality control , thus product sales are less sensitive to general economic conditions . instrument products and continuous monitoring systems have a longer life , and their purchase by our customers is somewhat discretionary , so sales are more sensitive to general economic conditions . service demand is driven by our customers ' quality control and regulatory environments , which require periodic repair and recalibration or certification of our instrument products and continuous monitoring systems . we typically evaluate costs and pricing annually . our policy is to price our products and systems competitively and , where possible , we try to pass along cost increases in order to maintain our margins . gross profit is affected by our product mix , manufacturing efficiencies and price competition . historically , as we have integrated our acquisitions and taken advantage of manufacturing efficiencies , our gross margins for some of the products have improved . there are , however , differences in gross margins between different product lines , and ultimately the mix of sales will continue to impact our overall gross margin . selling expense is driven primarily by labor costs , including salaries and commissions . accordingly , it may vary with sales levels . labor costs and amortization of intangible assets drive the substantial majority of general and administrative expense . research and development expense is predominantly comprised of labor costs and third party consultants . year ended march 31 , 2015 acquisitions during the year ended march 31 , 2015 , we completed the following six acquisitions ( the “ 2015 acquisitions ” ) : in march 2015 , we completed the früh acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of früh 's business segment associated with the distribution of our biological indicator products ; in february 2015 , we completed the cherwell acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of cherwell 's business segment associated with the distribution of our biological indicator products ; in october 2014 , we completed the ati acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of ati , a distributor of our biological indicator products ; in october 2014 , we completed the pcd acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of pcd 's business segment associated with the sale of pcd 's which are used for quality control purposes in the field of ethylene oxide sterilization of medical devices ; page 18 in april 2014 , we completed the bgi acquisition whereby we acquired substantially all of the assets ( other than cash and accounts receivable ) and certain liabilities of bgi 's business which is focused on the sale of equipment used primarily for particulate air sampling ; and in april 2014 , we completed the amilabo acquisition whereby we acquired all of the common stock of amilabo , a distributor of our biological indicator products . year ended march 31 , 2014 acquisitions during the year ended march 31 , 2014 , we completed the following three acquisitions ( the “ 2014 acquisitions ” ) : in november 2013 , we completed the tempsys acquisition whereby we acquired all of the common stock of tempsys , a company in the business of providing continuous monitoring systems to regulated industries ; in november 2013 , we completed the amega acquisition whereby we acquired substantially all of the assets ( other than cash ) and certain liabilities of amega , a company in the business of providing continuous monitoring services to regulated industries ; and in july 2013 , we completed the suretorque acquisition whereby we acquired substantially all the assets ( other than cash ) of st acquisition 's business segment involving the design , manufacture , sale and service of its suretorque line of bottle cap torque testing instrumentation . story_separator_special_tag while our estimates and assumptions are based on our knowledge of current events and actions we may undertake in the future , actual results may ultimately differ from these estimates and assumptions . for a discussion of our significant accounting policies , please see note 1 of notes to consolidated financial statements contained in “ item 8. financial statements and supplementary data . ” accounts receivable we estimate an allowance for doubtful accounts based on overall historic write-offs , the age of our receivable balances , and the payment history and creditworthiness of the customer . if actual results are not consistent with our assumptions and judgments or our assumptions and estimates change due to new information , we may experience material changes in our allowance for doubtful accounts and bad debt expense . inventories inventories are stated at the lower of cost or market , based on standards using the first-in , first-out method ( fifo ) to determine cost . we evaluate standard costs annually , unless circumstances necessitate a mid-year evaluation for specific items . our work in process and finished goods inventory includes labor and overhead , which are estimated based on trailing twelve months of expense and standard labor hours for each product . our biological indicator inventory is tracked by lot number , thus labor is generally based on actual hours . we monitor inventory cost compared to selling price in order to determine if a lower of cost or market reserve is necessary . at year end we perform a complete physical inventory observation . throughout the year , we estimate and maintain an inventory reserve , as needed , for such matters as obsolete inventory , shrink and scrap . this reserve may fluctuate as our assumptions change due to new information , discrete events , or changes in our business , such as entering new markets or discontinuing a specific product . page 26 recoverability of long-lived assets for property , plant and equipment , and intangible assets subject to amortization , recoverability and or impairment tests are required only when conditions exist that indicate the carrying value may not be recoverable . we monitor the same conditions for our goodwill , but an annual evaluation is also required . monitoring these conditions requires significant management judgment , including evaluating general economic conditions , industry and market considerations , changes in production costs , cash flow trends , and other relevant entity-specific events such as changes in management , key personnel , strategy or customers . if conditions exist that indicate the carrying value may not be recoverable , we would be required to estimate the fair value of the asset , asset group , or reporting unit . we determine fair value using widely accepted valuation techniques , primarily discounted cash flow and market multiple analyses . these techniques are also used when initially allocating the purchase price to acquired assets and liabilities . these types of analyses require us to make assumptions and estimates regarding industry and economic factors , the profitability of future business strategies , and cash flow . we did not record any impairment charges for the years ended march 31 , 2015 , 2014 or 2013. if actual results are not consistent with our assumptions and estimates , or our assumptions and estimates change due to new information , we may be exposed to an impairment charge in the future . purchase accounting for acquisitions we apply the acquisition method of accounting for a business combination . in general , this methodology requires companies to record assets acquired and liabilities assumed at their respective fair market values at the date of acquisition . any amount of the purchase price paid that is in excess of the estimated fair value of the net assets acquired is recorded as goodwill . for the pcd , amega and bios acquisitions , we also recorded a liability for contingent consideration based on estimated future revenues . we monitor our assumptions surrounding these estimated future cash flows and , if there is a significant change , would record an adjustment to the contingent consideration liability and a corresponding adjustment to either income or expense . we determine fair value using widely accepted valuation techniques , primarily discounted cash flow and market multiple analyses . these types of analyses require us to make assumptions and estimates regarding industry and economic factors , the profitability of future business strategies , discount rates and cash flow . if actual results are not consistent with our assumptions and estimates , or our assumptions and estimates change due to new information , we may be exposed to an impairment charge in the future . if the contingent consideration paid for any of our acquisitions differs from the amount initially recorded , we would record either income or expense . stock-based compensation we estimate the fair value of option grants using the black-scholes model , which requires us to estimate the volatility and forfeiture rate . under our current stock-based compensation plan , we recognize the expense on a straight-line basis over the service period . contingent liabilities we accrue a loss for contingencies if it is probable that an asset has been impaired or a liability has been incurred , and when the amount of loss can be reasonably estimable . when no accrual is made because one or both of these conditions does not exist , we disclose the contingency if there is at least a reasonable possibility that a loss may be incurred . we estimate contingent liabilities , such as for state sales taxes , based on the best information available at the time . if there is a range of possible outcomes , we accrue the low end of the range . recent accounting standards and pronouncements in may 2014 , the financial accounting standards board ( “ fasb ” ) and international accounting standards board ( “ iasb ” )

